A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Baylor College of Medicine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Fondazione Italiana Linfomi - ETS
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
Princess Maxima Center for Pediatric Oncology
Cancer Research UK
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
New York Medical College
M.D. Anderson Cancer Center
Universität des Saarlandes
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
University of Nebraska
Columbia University
Ruijin Hospital
Northwestern University
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
University of Nebraska
University of Nebraska
City of Hope Medical Center
University of Nebraska
The Lymphoma Academic Research Organisation
University of Nebraska
University of Nebraska
University of Milano Bicocca
City of Hope Medical Center
Ruijin Hospital
Massachusetts General Hospital
University of Milano Bicocca
Fred Hutchinson Cancer Center
Columbia University
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
Mayo Clinic